RS92304A - Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for long-term preservation of acute urinary retention - Google Patents
Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for long-term preservation of acute urinary retentionInfo
- Publication number
- RS92304A RS92304A YU92304A YUP92304A RS92304A RS 92304 A RS92304 A RS 92304A YU 92304 A YU92304 A YU 92304A YU P92304 A YUP92304 A YU P92304A RS 92304 A RS92304 A RS 92304A
- Authority
- RS
- Serbia
- Prior art keywords
- long
- pharmaceutical combination
- benign prostatic
- prostatic hyperplasia
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Ovaj pronalazak se odnosi na nove farmaceutske kombinacije za tretman benigne hiperplazije prostate (BPH) ili dugotrajne prevencije akutnog zadržavanja mokraće (AUR).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2002118392 DE10218392A1 (de) | 2002-04-24 | 2002-04-24 | Verwendung von Arzneimittelkombinationen zur Behandlung von benigner Prostatahyperplasie |
DE2002118611 DE10218611A1 (de) | 2002-04-25 | 2002-04-25 | Verwendung einer Tamsulosin enthaltenden Arzneimittelkombination zur Behandlung von benigner Prostatahyperplasie |
PCT/EP2003/004034 WO2003090753A1 (en) | 2002-04-24 | 2003-04-17 | Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention |
Publications (1)
Publication Number | Publication Date |
---|---|
RS92304A true RS92304A (en) | 2006-10-27 |
Family
ID=29271571
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU92304A RS92304A (en) | 2002-04-24 | 2003-04-17 | Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for long-term preservation of acute urinary retention |
Country Status (22)
Country | Link |
---|---|
US (2) | US20030225118A1 (sr) |
EP (2) | EP1743656A3 (sr) |
JP (1) | JP2005524693A (sr) |
CN (1) | CN1646135A (sr) |
AT (1) | ATE361075T1 (sr) |
AU (1) | AU2003227643A1 (sr) |
BR (1) | BR0309435A (sr) |
CA (1) | CA2479992A1 (sr) |
CY (1) | CY1107674T1 (sr) |
DE (1) | DE60313603T2 (sr) |
DK (1) | DK1501517T3 (sr) |
EA (1) | EA008377B1 (sr) |
ES (1) | ES2287474T3 (sr) |
HR (1) | HRP20040994A2 (sr) |
IL (1) | IL163976A0 (sr) |
MX (1) | MXPA04010408A (sr) |
NO (1) | NO20044333L (sr) |
NZ (1) | NZ536514A (sr) |
PL (1) | PL371430A1 (sr) |
PT (1) | PT1501517E (sr) |
RS (1) | RS92304A (sr) |
WO (1) | WO2003090753A1 (sr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1501517T3 (da) * | 2002-04-24 | 2007-06-11 | Boehringer Ingelheim Pharma | Farmaceutisk kombination til behandling af godartet hyperplasia af prostata eller til langtidsforhindring af akut urinretention |
AU2004285289A1 (en) * | 2003-11-03 | 2005-05-12 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, containing a beta-3-adrenoceptor agonist and an alpha antagonist and/or a 5-alpha-reductase inhibitor |
US7601994B2 (en) * | 2003-11-14 | 2009-10-13 | Semiconductor Energy Laboratory Co., Ltd. | Display device and method for manufacturing the same |
WO2006055659A2 (en) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Fixed dose combination op dutasteride and tamsulosin |
CN102309495A (zh) * | 2010-06-30 | 2012-01-11 | 北京润德康医药技术有限公司 | 一种复方制剂及其制备方法 |
WO2012110092A1 (en) | 2011-02-17 | 2012-08-23 | Synthon Bv | Tamsulosin derivatives |
BRPI1103204A2 (pt) * | 2011-06-03 | 2014-02-25 | Eurofarma Lab S A | Composição farmacêutica para o tratamento de hiperplasia prostática benigna |
WO2013123965A1 (en) | 2012-02-20 | 2013-08-29 | Synthon Bv | A fixed dose pharmaceutical formulation |
US10596127B2 (en) | 2013-03-14 | 2020-03-24 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
BR102013020508B1 (pt) * | 2013-08-12 | 2021-01-12 | Ems S/A. | Forma de dosagem que compreende um inibidor de esteroide 5-alfa-redutase e um bloqueador alfa, processo para a preparaçãode uma forma de dosagem e uso da forma de dosagem |
ES2555485T1 (es) | 2014-05-26 | 2016-01-04 | Galenicum Health S.L. | Composiciones farmacéuticas que contienen un agente activo |
WO2017058436A1 (en) * | 2015-09-30 | 2017-04-06 | Wellesley Pharmaceuticals, Llc | Composition for reducing the frequency of urination, method of making and use thereof |
US10172910B2 (en) * | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
CN115969860A (zh) * | 2021-10-14 | 2023-04-18 | 上海汇伦医药股份有限公司 | 一种药物组合物及其用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5391825A (en) * | 1980-02-08 | 1995-02-21 | Yamanouchi Pharmaceutical Co., Ltd. | Sulfamoyl substituted phenethylamine intermediates |
JPS56110665A (en) | 1980-02-08 | 1981-09-01 | Yamanouchi Pharmaceut Co Ltd | Sulfamoyl-substituted phenetylamine derivative and its preparation |
US4760071A (en) | 1984-02-27 | 1988-07-26 | Merck & Co., Inc. | 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors |
NZ211145A (en) | 1984-02-27 | 1988-10-28 | Merck & Co Inc | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions |
US4772475A (en) | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
EP0285382B1 (en) | 1987-04-03 | 1994-04-13 | Merck & Co. Inc. | Treatment of androgenic alopecia with 17beta-n-monosubstituted-carbamoyl-4-aza-5alpha-androst-1-en-3-ones |
DE3888378T2 (de) | 1987-04-03 | 1994-09-29 | Merck & Co Inc | Behandlung von Prostatacarcinoma mit 17-beta-n-monosubstituierten-Carbamoyl-4-aza-5-alpha-Androst-1-en-3-onen. |
NZ241979A (en) * | 1991-03-20 | 1996-01-26 | Merck & Co Inc | Treatment of benign prostatic hyperplasia using 5alpha-reductase inhibitor and an alpha1-adrenergic recepter blocker |
TW369521B (en) | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
TW382595B (en) | 1993-10-15 | 2000-02-21 | Merck & Co Inc | Pharmaceutical composition for use in arresting and reversing androgenic alopecia |
US6423719B1 (en) * | 1999-02-16 | 2002-07-23 | Upsher-Smith Laboratories, Inc. | Method for treating benign prostate hyperplasia |
WO2001021167A1 (en) * | 1999-09-22 | 2001-03-29 | Merck & Co., Inc. | Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein |
DK1501517T3 (da) * | 2002-04-24 | 2007-06-11 | Boehringer Ingelheim Pharma | Farmaceutisk kombination til behandling af godartet hyperplasia af prostata eller til langtidsforhindring af akut urinretention |
-
2003
- 2003-04-17 DK DK03725053T patent/DK1501517T3/da active
- 2003-04-17 DE DE60313603T patent/DE60313603T2/de not_active Revoked
- 2003-04-17 ES ES03725053T patent/ES2287474T3/es not_active Expired - Lifetime
- 2003-04-17 NZ NZ536514A patent/NZ536514A/en unknown
- 2003-04-17 BR BR0309435-9A patent/BR0309435A/pt not_active Expired - Fee Related
- 2003-04-17 MX MXPA04010408A patent/MXPA04010408A/es active IP Right Grant
- 2003-04-17 CN CNA038089300A patent/CN1646135A/zh active Pending
- 2003-04-17 CA CA002479992A patent/CA2479992A1/en not_active Abandoned
- 2003-04-17 EP EP06122312A patent/EP1743656A3/en not_active Withdrawn
- 2003-04-17 PT PT03725053T patent/PT1501517E/pt unknown
- 2003-04-17 EA EA200401340A patent/EA008377B1/ru not_active IP Right Cessation
- 2003-04-17 WO PCT/EP2003/004034 patent/WO2003090753A1/en active IP Right Grant
- 2003-04-17 PL PL03371430A patent/PL371430A1/xx not_active Application Discontinuation
- 2003-04-17 EP EP03725053A patent/EP1501517B1/en not_active Revoked
- 2003-04-17 AU AU2003227643A patent/AU2003227643A1/en not_active Abandoned
- 2003-04-17 IL IL16397603A patent/IL163976A0/xx unknown
- 2003-04-17 AT AT03725053T patent/ATE361075T1/de active
- 2003-04-17 JP JP2003587387A patent/JP2005524693A/ja active Pending
- 2003-04-17 RS YU92304A patent/RS92304A/sr unknown
- 2003-04-24 US US10/422,509 patent/US20030225118A1/en not_active Abandoned
-
2004
- 2004-10-12 NO NO20044333A patent/NO20044333L/no not_active Application Discontinuation
- 2004-10-22 HR HR20040994A patent/HRP20040994A2/hr not_active Application Discontinuation
-
2007
- 2007-04-06 US US11/697,470 patent/US20070197666A1/en not_active Abandoned
- 2007-06-14 CY CY20071100794T patent/CY1107674T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EA008377B1 (ru) | 2007-04-27 |
NZ536514A (en) | 2006-11-30 |
IL163976A0 (en) | 2005-12-18 |
NO20044333L (no) | 2004-11-09 |
CN1646135A (zh) | 2005-07-27 |
BR0309435A (pt) | 2005-02-15 |
ATE361075T1 (de) | 2007-05-15 |
EA200401340A1 (ru) | 2005-06-30 |
US20030225118A1 (en) | 2003-12-04 |
PL371430A1 (en) | 2005-06-13 |
US20070197666A1 (en) | 2007-08-23 |
AU2003227643A1 (en) | 2003-11-10 |
DE60313603T2 (de) | 2008-01-03 |
ES2287474T3 (es) | 2007-12-16 |
PT1501517E (pt) | 2007-05-31 |
WO2003090753A1 (en) | 2003-11-06 |
CY1107674T1 (el) | 2013-04-18 |
JP2005524693A (ja) | 2005-08-18 |
MXPA04010408A (es) | 2005-02-17 |
EP1743656A3 (en) | 2007-03-07 |
EP1743656A2 (en) | 2007-01-17 |
EP1501517A1 (en) | 2005-02-02 |
DE60313603D1 (de) | 2007-06-14 |
HRP20040994A2 (en) | 2005-02-28 |
DK1501517T3 (da) | 2007-06-11 |
WO2003090753A8 (en) | 2004-11-04 |
CA2479992A1 (en) | 2003-11-06 |
EP1501517B1 (en) | 2007-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107674T1 (el) | Φαρμακευτικος συνδυασμος για τη θεραπευτικη αντιμετωπιση της καλοηθους υπερπλασιας του προστατη ή για την μακροπροθεσμη προληψη της οξειας επισχεσης ουρων | |
BRPI0307699A2 (pt) | Tratamento de hiperplasia benigna da próstata com sarms. | |
DE60023982D1 (de) | System zur Behandlung von benigner Prostatahyperplasie | |
IL169685A0 (en) | Treatment of benign prostatic hyperplasia using energolytic agents | |
EP1212055A4 (en) | NEUROTHERAPEUTIC COMPOSITION AND METHOD | |
MY112949A (en) | Benzo-thiaphene estrogen agonists to treat prostatic hyperplasia | |
BR0013219A (pt) | Métodos de tratamento ou inibição de pólipos de cólon, de tratamento ou inibição de câncer colorretal, uso de uma combinação de nsaid e de um inibidor de egfr quinase, composição farmacêutica, e, produto | |
HUP0104688A2 (hu) | Összetételek és eljárások a rákbetegség és a rákbetegséggel kapcsolódó csontveszteség megelőzéséhez és kezeléséhez | |
AU3011299A (en) | Combination therapy for the treatment of benign prostatic hyperplasia | |
WO2001030333A3 (en) | Tissue factor antagonists and methods of use thereof | |
AU2001260880A1 (en) | Pharmaceutical compounds for treating copd | |
MY118986A (en) | Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
DK0885005T3 (da) | Anvendelse af dehydroepiandrosteron og aromatasehæmmere til fremstilling af et lægemiddel til behandling af en relativ og absolut androgenmangel hos mænd | |
PL357179A1 (en) | Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers | |
PL370361A1 (en) | Alkyl urea retinoid agonists i | |
WO2007141661A3 (en) | Herbal compositions for the prevention or treatment of benign prostatic hyperplasia | |
EA200401100A1 (ru) | 1α-ФТОР-25-ГИДРОКСИ-16,23E-ДИЕН-26,27-БИСГОМО-20-ЭПИХОЛЕКАЛЬЦИФЕРОЛ И ЕГО ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ | |
MXPA04005942A (es) | Composiciones y metodos de sintaxina 3. | |
GB0301016D0 (en) | Treatment of benign prostatic hyperplasia | |
SI1501517T1 (sl) | Farmacevtska kombinacija za zdravljenje benigne hiperplazije prostate ali za dolgotrajno preprečevanje akutne retencije urina | |
EP1485117A4 (en) | METHOD FOR THERAPEUTIC TREATMENT OF BENIGN PROSTATE HYPERTROPHY (BPH) | |
NO975838L (no) | Melatoninagonister for behandling av godartet prostatisk hyperplasi | |
EP1435913A4 (en) | METHOD OF TREATING BENIGN PROSTATIC HYPERPLASIA AND OTHER BENCH PROSTATIC PATHOLOGIES | |
MX9710075A (es) | Antagonistas melatonina para el tratamiento en la hiperplasia prostatica benigna. | |
GB9810895D0 (en) | Combination therapy for the treatment of benign prostatic hyperplasia |